|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | C07H 19/06 | |
| C07H 19/16 | |||
| C07H 19/14 | |||
| A61K 31/7064 | |||
| A61K 31/7076 | |||
| A61P 31/12 |
| (11) | Patento numeris | 1633766 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 04775900.6 |
| Europos patento paraiškos padavimo data | 2004-04-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-03-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-03-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2004/012472 |
| Data | 2004-04-21 |
| (87) | Numeris | WO 2005/003147 |
| Data | 2005-01-13 |
| (30) | Numeris | Data | Šalis |
| 474368 P | 2003-05-30 | US |
| (72) |
CLARK, Jeremy, US
|
| (73) |
Gilead Pharmasset LLC,
c/o Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, CA 94404,
US
|
| (54) | MODIFIED FLUORINATED NUCLEOSIDE ANALOGUES |
| MODIFIED FLUORINATED NUCLEOSIDE ANALOGUES |